Clinical Trial Detail

NCT ID NCT03154827
Title A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects With Acute Myeloid Leukemia Who Are 60 Years or Older - The BATTLE Study
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioLineRx, Ltd.
Indications

acute myeloid leukemia

Therapies

Atezolizumab + BKT140

Age Groups: senior adult

No variant requirements are available.